Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration. (Q37588236)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712953%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

review article

1 reference

title

Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712953%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712953%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Ahmed Mudawi Musa

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712953%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sassan Noazin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712953%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Farrokh Modabber

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712953%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

26 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712953%20AND%20SRC:MED&resulttype=core&format=json

Transactions of the Royal Society of Tropical Medicine and Hygiene

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712953%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712953%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712953%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712953%20AND%20SRC:MED&resulttype=core&format=json

Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.026

Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.026

Immunotherapy for drug-refractory mucosal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.026

The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.026

The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: Does ultraviolet light (UVB) radiation play a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.026

Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990-99

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2009.07.026

10.1016/J.TRSTMH.2009.07.026

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19712953%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference